Shri Swami Samarth Pharmaceuticals Limited

Manufactures and trades medicines, drugs, and pharmaceutical products in Maharashtra.

2004 | Aurangabad, Maharashtra (India) | Active
Last Updated:

Shri Swami Samarth Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 20 Year, 4 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 1.67 M
  • Revenue Growth 7.48%
  • Profit Growth -68.79%
  • Ebitda -164.50%
  • Net Worth 9.62%
  • Total Assets -19.37%

About Shri Swami Samarth Pharmaceuticals

Shri Swami Samarth Pharmaceuticals Limited (SSSPL) is a Public Limited Indian Non-Government Company incorporated in India on 08 October 2004 and has a history of 20 years and four months. Its registered office is in Aurangabad, Maharashtra, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.50 M.

The company currently has active open charges totaling ₹1.67 M.

Shahadev Patil, Vaishali Shahadev, and Tejaswini Patil serve as directors at the Company.

Company Details

  • Location

    Aurangabad, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24230MH2004PLC149048

  • Company No.

    149048

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    08 Oct 2004

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Pharma

Who are the key members and board of directors at Shri Swami Samarth Pharmaceuticals?

Board Members (3)

NameDesignationAppointment DateStatus
Shahadev Patil Country flag representing In Director 05-Apr-2022Current
Vaishali Shahadev Country flag representing In Director 05-Apr-2022Current
Tejaswini Patil Country flag representing In Director 05-Apr-2022Current

Financial Performance of Shri Swami Samarth Pharmaceuticals.

Shri Swami Samarth Pharmaceuticals Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.48% increase. The company also saw a substantial fall in profitability, with a 68.79% decrease in profit. The company's net worth moved up by a moderate rise of 9.62%.

Shri Swami Samarth Pharmaceuticals revenue growth over time
Shri Swami Samarth Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
7.48%
Revenue from Operations
-2.23%
Total Assets
-19.37%
Profit or Loss
-68.79%
Net Worth
9.62%
EBITDA
-164.50%

What is the Ownership and Shareholding Structure of Shri Swami Samarth Pharmaceuticals?

In 2023, Shri Swami Samarth Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹1.67 M

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • State Bank Of Hyerabad : 0.09 Cr
  • Hdfc Bank Limited : 0.08 Cr

Latest Charge Details

DateLenderAmountStatus
31 Jul 2023Hdfc Bank Limited₹0.77 MOpen
21 Mar 2005State Bank Of Hyerabad₹0.90 MOpen

How Many Employees Work at Shri Swami Samarth Pharmaceuticals?

Shri Swami Samarth Pharmaceuticals has a workforce of 17 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Shri Swami Samarth Pharmaceuticals Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Shri Swami Samarth Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shri Swami Samarth Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Shri Swami Samarth Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Shri Swami Samarth Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Shri Swami Samarth Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 0.77 M with Charge ID 100812823 was registered on 31 Jul 2023.

  • Director Appointment

    Shahadev Ganpatrao Patil was appointed as a Director was appointed as a Director on 05 Apr 2022 & has been associated with this company since 2 years 10 months .

  • Director Appointment

    Vaishali Patil Shahadev was appointed as a Director was appointed as a Director on 05 Apr 2022 & has been associated with this company since 2 years 10 months .

  • Director Appointment

    Tejaswini Shahadev Patil was appointed as a Director was appointed as a Director on 05 Apr 2022 & has been associated with this company since 2 years 10 months .

Frequently asked questions

  • What is the Incorporation or founding date of Shri Swami Samarth Pharmaceuticals Limited?

    Shri Swami Samarth Pharmaceuticals Limited was incorporated on 08 Oct 2004.

  • What is authorized share capital and paid-up capital of Shri Swami Samarth Pharmaceuticals Limited?

    The authorized share capital of Shri Swami Samarth Pharmaceuticals Limited is ₹ 1.50 M and paid-up capital is ₹ 0.50 M.

  • Who are the current board members & directors of Shri Swami Samarth Pharmaceuticals Limited?

    Currently 3 directors are associated with Shri Swami Samarth Pharmaceuticals Limited.

    • Shahadev Ganpatrao Patil
    • Vaishali Patil Shahadev
    • Tejaswini Shahadev Patil

  • What is the registered address of Shri Swami Samarth Pharmaceuticals Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Shri Swami Samarth Pharmaceuticals Limited is C-24 Chikalthana, India, Aurangabad, Maharashtra, 431006.

  • What is the corporate identification number (CIN) and company number of Shri Swami Samarth Pharmaceuticals Limited?

    The corporate identification number (CIN) of Shri Swami Samarth Pharmaceuticals Limited is U24230MH2004PLC149048 and the company number is 149048 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Shri Swami Samarth Pharmaceuticals Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Shri Swami Samarth Pharmaceuticals Limited has risen by 7.48%.

  • How many employees does Shri Swami Samarth Pharmaceuticals Limited currently have?

    As Per 2023 financial reports, 17 employees are currently employed by Shri Swami Samarth Pharmaceuticals Limited.

  • What change has been observed in the net worth of Shri Swami Samarth Pharmaceuticals Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Shri Swami Samarth Pharmaceuticals Limited has experienced an upsurge of 9.62%.

  • What are the total open charges for Shri Swami Samarth Pharmaceuticals Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Shri Swami Samarth Pharmaceuticals Limited amount to ₹ 1.67 M.

  • When was the last Balance Sheet of Shri Swami Samarth Pharmaceuticals Limited filed with the ROC?

    The most recent Balance Sheet for Shri Swami Samarth Pharmaceuticals Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Drug Formulation & Development